145 related articles for article (PubMed ID: 11914631)
1. Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdissection-based allelotyping.
Dacic S; Finkelstein SD; Sasatomi E; Swalsky PA; Yousem SA
Am J Surg Pathol; 2002 Apr; 26(4):510-6. PubMed ID: 11914631
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity analysis shows monoclonal evolution with frequent genetic progression and divergence in esophageal carcinosarcoma.
Matsumoto T; Fujii H; Arakawa A; Yamasaki S; Sonoue H; Hattori K; Kajiyama Y; Hirose S; Tsurumaru M
Hum Pathol; 2004 Mar; 35(3):322-7. PubMed ID: 15017588
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloalveolar carcinoma indicate a similar molecular pathogenesis.
Dacic S; Sasatomi E; Swalsky PA; Kim DW; Finkelstein SD; Yousem SA
Arch Pathol Lab Med; 2004 Aug; 128(8):880-4. PubMed ID: 15270615
[TBL] [Abstract][Full Text] [Related]
4. Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity.
Fujii H; Yoshida M; Gong ZX; Matsumoto T; Hamano Y; Fukunaga M; Hruban RH; Gabrielson E; Shirai T
Cancer Res; 2000 Jan; 60(1):114-20. PubMed ID: 10646862
[TBL] [Abstract][Full Text] [Related]
5. Genotypic analysis of pulmonary Langerhans cell histiocytosis.
Dacic S; Trusky C; Bakker A; Finkelstein SD; Yousem SA
Hum Pathol; 2003 Dec; 34(12):1345-9. PubMed ID: 14691922
[TBL] [Abstract][Full Text] [Related]
6. Patterns of allelic loss of synchronous adenocarcinomas of the lung.
Dacic S; Ionescu DN; Finkelstein S; Yousem SA
Am J Surg Pathol; 2005 Jul; 29(7):897-902. PubMed ID: 15958854
[TBL] [Abstract][Full Text] [Related]
7. Carcinosarcoma of the urinary bladder following cyclophosphamide therapy: evidence for monoclonal origin and chromosome 9p allelic loss.
Mukhopadhyay S; Shrimpton AE; Jones LA; Nsouli IS; Abraham NZ
Arch Pathol Lab Med; 2004 Jan; 128(1):e8-11. PubMed ID: 14692829
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous basal cell carcinosarcomas: evidence of clonality and recurrent chromosomal losses.
Harms PW; Fullen DR; Patel RM; Chang D; Shalin SC; Ma L; Wood B; Beer TW; Siddiqui J; Carskadon S; Wang M; Palanisamy N; Fisher GJ; Andea A
Hum Pathol; 2015 May; 46(5):690-7. PubMed ID: 25704628
[TBL] [Abstract][Full Text] [Related]
9. Gliosarcoma with epithelial differentiation: immunohistochemical and molecular characterization. A case report and review of the literature.
Ozolek JA; Finkelstein SD; Couce ME
Mod Pathol; 2004 Jun; 17(6):739-45. PubMed ID: 15148503
[TBL] [Abstract][Full Text] [Related]
10. Hepatic carcinosarcoma: evidence of polyclonal origin based on microsatellite analysis.
Gu YJ; Zhu YY; Lu XY; Zhao Q; Cong WM
Pathol Res Pract; 2015 Dec; 211(12):905-10. PubMed ID: 26452486
[TBL] [Abstract][Full Text] [Related]
11. Microdissection-based mutational genotyping of serous borderline tumors of the ovary.
Krishnamurti U; Sasatomi E; Swalsky PA; Jones MW; Finkelstein SD
Int J Gynecol Pathol; 2005 Jan; 24(1):56-61. PubMed ID: 15626917
[TBL] [Abstract][Full Text] [Related]
12. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
Gradowski JF; Mantha GS; Hunt JL; Dacic S
Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features and genomic analysis of pulmonary blastomatoid carcinosarcoma.
Zhao J; Xiang C; Zhao R; Guo P; Zheng J; Han-Zhang H; Yu K; Zhang J; Han Y
BMC Cancer; 2020 Mar; 20(1):248. PubMed ID: 32209061
[TBL] [Abstract][Full Text] [Related]
14. Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma.
Finkelstein SD; Marsh W; Demetris AJ; Swalsky PA; Sasatomi E; Bonham A; Subotin M; Dvorchik I
Hepatology; 2003 Apr; 37(4):871-9. PubMed ID: 12668980
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity in clonal evolution with genetic progression and divergence in spindle cell carcinoma of the gallbladder.
Arakawa A; Fujii H; Matsumoto T; Hirai S; Suda K
Hum Pathol; 2004 Apr; 35(4):418-23. PubMed ID: 15116321
[TBL] [Abstract][Full Text] [Related]
17. p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implications for histogenesis.
Holst VA; Finkelstein S; Colby TV; Myers JL; Yousem SA
Am J Surg Pathol; 1997 Jul; 21(7):801-11. PubMed ID: 9236836
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.
Pan H; Califano J; Ponte JF; Russo AL; Cheng KH; Thiagalingam A; Nemani P; Sidransky D; Thiagalingam S
Cancer Res; 2005 Mar; 65(5):1664-9. PubMed ID: 15753360
[TBL] [Abstract][Full Text] [Related]
19. [Distinguishing second primary tumors from lung metastasis in patients with postoperative non-small cell lung cancer by microsatellite analysis].
Wang J; Lu C; Liu XY; Zhang HB; Zhao J; Yang L; Guo QZ; An TT; Wu MN
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):103-7. PubMed ID: 17445470
[TBL] [Abstract][Full Text] [Related]
20. Clonal selection of adenocarcinoma of the lung as determined by loss of heterozygosity.
Dacic S; Finkelstein SD; Yousem SA
Exp Mol Pathol; 2005 Apr; 78(2):135-9. PubMed ID: 15713439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
